Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medifast Inc (MED)

Medifast Inc (MED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Medifast, Inc. (NYSE: MED)

NEW YORK , April 14, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Medifast, Inc. (NYSE: MED) on behalf of the company's shareholders.  The investigation seeks...

MED : 10.76 (+1.22%)
3 Consumer Stocks That Concern Us

3 Consumer Stocks That Concern Us

POST : 100.63 (+0.77%)
USNA : 18.44 (+1.49%)
MED : 10.76 (+1.22%)
3 of Wall Street’s Favorite Stocks We Steer Clear Of

3 of Wall Street’s Favorite Stocks We Steer Clear Of

AIZ : 222.50 (+0.04%)
SHAK : 102.14 (+1.48%)
MED : 10.76 (+1.22%)
3 Reasons MED is Risky and 1 Stock to Buy Instead

3 Reasons MED is Risky and 1 Stock to Buy Instead

MED : 10.76 (+1.22%)
1 Small-Cap Stock with Exciting Potential and 2 We Find Risky

1 Small-Cap Stock with Exciting Potential and 2 We Find Risky

LMB : 86.59 (+1.07%)
ROG : 117.10 (-1.64%)
MED : 10.76 (+1.22%)
Winners And Losers Of Q4: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks

Winners And Losers Of Q4: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks

MED : 10.76 (+1.22%)
Medifast Announces Cooperation Agreement with Steamboat Capital

Company Agrees to Nominate Parsa Kiai and Jeff Rose as Director Candidates at 2026 Annual Meeting of Stockholders

MED : 10.76 (+1.22%)
3 Out-of-Favor Stocks with Open Questions

3 Out-of-Favor Stocks with Open Questions

PZZA : 34.81 (-0.57%)
OLED : 97.89 (-2.62%)
MED : 10.76 (+1.22%)
Medifast’s Q4 Earnings Call: Our Top 5 Analyst Questions

Medifast’s Q4 Earnings Call: Our Top 5 Analyst Questions

MED : 10.76 (+1.22%)
Scientific Evidence Demonstrates OPTAVIA®’s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients

As part of its continued focus on improving metabolic health, Medifast ® (NYSE: MED) today announced that OPTA VIA ’s comprehensive metabolic...

MED : 10.76 (+1.22%)

Barchart Exclusives

Why Citi Analysts Are Betting IBM Stock Can Gain Nearly 20% From Here
Citi recently initiated coverage on IBM with a "Buy" rating and a $285 price target. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.